Indeed, the chronotropic effects of GLP-1RAs may be deleterious in HF patients, with higher sympathetic activity contributing to morbidity and mortality [20]
This broader activity increases the risk of side effects like fatigue, nausea, and appetite changes
GHK-Cu adds a layer of skin and connective tissue support, while KPV manages the underlying inflammation that can hinder the healing process
For any regulatory help for your drug to launch in the market or any patent-related procedures, our experienced team at Artixio is ready to help you make your regulatory journey easy and help you achieve success with your pharma product in the market
Emerging Applications Currently, drugs like semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Victoza, Saxenda) are FDA-approved for managing type 2 diabetes and chronic weight management